Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06709313
PHASE4

Effect of Chromium on Blood Sugar After Sacroiliac Joint Injection

Sponsor: Fayoum University

View on ClinicalTrials.gov

Summary

The aim of this study is to investigate whether oral chromium supplementation can decrease steroid-induced hyperglycemia in diabetic patients undergoing ultrasound-guided sacroiliac joint injections through a randomized controlled trial (RCT).

Official title: Does Oral Chromium Withstand Steroid Hyperglycemia in Post-interventional Ultrasound Guided Sacroiliac Joint Injection in Diabetic Patients

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2024-06-03

Completion Date

2025-05

Last Updated

2024-11-29

Healthy Volunteers

No

Interventions

DRUG

Chromium

Participants in the experimental group will receive oral chromium supplementation, the dosage of which is determined based on previous studies(200 mcg daily) taking into account safety and efficacy considerations. The supplementation will commence for 45 days following the injection.

Locations (1)

FAYOUM University hospital

Al Fayyum, Egypt